Fundamentals of the HLA System: An Educational Overview
The human leukocyte antigen (HLA) system, also known as the major histocompatibility complex (MHC) in humans, is a cornerstone of adaptive immunity. Understanding its structure, function, and clinical relevance is essential for students of pathology, immunology, and clinical medicine. This course synthesizes key concepts tested in a recent quiz, providing a comprehensive, SEO‑optimized guide to the HLA system.
Structural Organization of the HLA Locus
The HLA genes are clustered on chromosome 6p21 and are divided into three main regions: class I, class II, and class III. Each region encodes distinct proteins with specific immunological roles.
Class I Region
HLA‑A, HLA‑B, and HLA‑C are the classical class I molecules that present endogenous peptides to CD8⁺ cytotoxic T lymphocytes. These molecules are expressed on almost all nucleated cells and associate with the invariant β₂‑microglobulin chain.
Class II Region
Class II genes include HLA‑DR, HLA‑DQ, and HLA‑DP. They are primarily expressed on professional antigen‑presenting cells (APCs) such as dendritic cells, macrophages, and B cells, presenting exogenous peptides to CD4⁺ helper T cells.
Class III Region
The class III region does not encode antigen‑presenting molecules but contains genes for complement components C4 and C2, as well as cytokines like tumor necrosis factor (TNF). This region underscores the close evolutionary link between HLA and innate immunity.
Antigen Presentation Pathways
Two distinct pathways govern how peptides are loaded onto HLA molecules, shaping the immune response.
Endogenous Pathway – HLA Class I
Proteins synthesized within the cell are degraded by the proteasome, and resulting peptides are transported into the endoplasmic reticulum (ER) by TAP (Transporter associated with Antigen Processing). Inside the ER, peptides bind to nascent HLA‑A, ‑B, or ‑C molecules. The peptide‑HLA complex then travels to the cell surface, where it can be recognized by CD8⁺ T cells. For example, the quiz question "Which HLA class I molecule presents endogenous peptides to CD8⁺ T cells?" highlights HLA‑A as a correct answer.
Exogenous Pathway – HLA Class II
External proteins are internalized by APCs, degraded in endosomal/lysosomal compartments, and loaded onto class II molecules. A crucial player in this process is the invariant chain (Ii), which blocks the peptide‑binding groove of nascent HLA‑DR, ‑DQ, and ‑DP molecules while they travel through the Golgi. In the acidic endosome, Ii is degraded, leaving the CLIP fragment that is later exchanged for antigenic peptides. The quiz item "What is the primary function of the invariant chain (Li) during HLA class II synthesis?" emphasizes this protective role.
Genetic Inheritance and Codominance
HLA genes are inherited as a tightly linked haplotype, and each allele is expressed in a codominant manner. This means that both maternal and paternal alleles are simultaneously transcribed and presented on the cell surface, providing a broad repertoire of peptide binding specificities.
The quiz question "Which of the following best describes codominance in HLA inheritance?" confirms that "Both parental alleles are expressed simultaneously in the offspring" is the accurate description.
Thymic Selection and HLA Molecules
During T‑cell development in the thymus, HLA molecules play a pivotal role in shaping the T‑cell repertoire.
Negative Selection of CD8⁺ T Cells
cortical thymic epithelial cells (cTECs) express high levels of class I HLA molecules. These present self‑peptides to developing CD8⁺ thymocytes. Cells that bind too strongly undergo apoptosis, a process known as negative selection, preventing autoimmunity. The quiz correctly identifies "HLA class I expressed on cortical thymic epithelial cells" as the primary mediator of this selection step.
Interaction with Natural Killer (NK) Cells
NK cells monitor the expression of HLA class I molecules to distinguish healthy cells from stressed or transformed cells. The concept of "missing‑self" recognition describes how loss of classical HLA‑A, ‑B, or ‑C triggers NK activation.
Role of HLA‑E and KIR Receptors
When a tumor cell down‑regulates classical class I molecules but retains HLA‑E, it can engage inhibitory killer‑cell immunoglobulin‑like receptors (KIR) on NK cells, delivering a "do not kill" signal. This mechanism is highlighted in the quiz item about NK activity, where the correct answer is "Inhibition of NK killing via KIR receptors".
Clinical Associations of Specific HLA Alleles
Beyond basic immunology, certain HLA alleles are strongly linked to drug hypersensitivity and autoimmune diseases.
Drug‑Induced Adverse Reactions
The allele HLA‑B*58:01 is a well‑documented risk factor for allopurinol‑induced DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Recognizing this association enables pre‑emptive genetic screening, reducing severe adverse events. The quiz correctly matches HLA‑B*58:01 with allopurinol‑induced DRESS.
Autoimmune and Neurological Disorders
One of the strongest genetic predispositions for narcolepsy is the presence of HLA‑DRB1*15:01. This allele influences the presentation of hypocretin‑related peptides, contributing to the loss of orexin‑producing neurons. The quiz confirms this link.
HLA and Complement Genes: The Class III Region
While class I and II genes dominate discussions of antigen presentation, the class III region houses complement components C4 and C2, which are essential for opsonization and clearance of immune complexes. Understanding this genomic layout helps explain why certain HLA haplotypes are associated with complement deficiencies or hyperactivity.
Key Take‑aways for Pathology Students
- Class I molecules (HLA‑A, ‑B, ‑C) present intracellular peptides to CD8⁺ T cells; loss of these molecules can trigger NK cell activation unless compensated by HLA‑E.
- Class II molecules (HLA‑DR, ‑DQ, ‑DP) rely on the invariant chain to prevent premature peptide loading and ensure proper antigen presentation to CD4⁺ T cells.
- HLA genes are inherited codominantly, providing a diverse peptide‑binding repertoire.
- The class III region encodes complement proteins C4 and C2, linking adaptive and innate immunity.
- Specific alleles such as HLA‑B*58:01 and HLA‑DRB1*15:01 have clinically actionable associations with drug reactions and narcolepsy, respectively.
- Thymic negative selection of CD8⁺ T cells depends on class I expression by cortical thymic epithelial cells.
- NK cell inhibition via HLA‑E/KIR interaction illustrates the balance between self‑tolerance and immune surveillance.
Further Reading and Resources
To deepen your understanding, explore the following reputable sources:
- Fundamentals of Immunology – Chapter on MHC molecules
- The IPD‑IMGT/HLA Database – Comprehensive allele information
- Pharmacogenomics of HLA‑Associated Drug Hypersensitivity
- HLA and Autoimmune Disease Associations
Conclusion
The HLA system integrates genetic diversity, antigen presentation, and clinical outcomes into a single, highly coordinated network. Mastery of its fundamentals—class I and II pathways, codominant inheritance, thymic selection, NK cell interactions, and disease‑linked alleles—equips pathology students with the knowledge to interpret laboratory results, anticipate drug reactions, and appreciate the genetic basis of immune‑mediated diseases. By revisiting the quiz questions within this structured framework, learners can reinforce their understanding and apply it to real‑world clinical scenarios.
